Gland Pharma Limited (GLAND) — Capital Reinvestment Ratio
Gland Pharma Limited (GLAND) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs5.93 Billion) in capital expenditures (Rs1.94 Billion). Check Gland Pharma Limited tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gland Pharma Limited Capital Reinvestment Ratio (2017–2026)
This chart tracks Gland Pharma Limited's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Gland Pharma Limited (GLAND) cash conversion ratio.
Annual Capital Reinvestment Ratio for Gland Pharma Limited (2017–2026)
Year-by-year Capital Reinvestment Ratio for Gland Pharma Limited from 2017 to 2026. See Gland Pharma Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.40x | Rs12.31 Billion | Rs4.91 Billion | ▼ -5.2% |
| 2025 | 0.42x | Rs9.15 Billion | Rs3.85 Billion | ▲ +7.5% |
| 2024 | 0.39x | Rs9.97 Billion | Rs3.90 Billion | ▼ -36.2% |
| 2023 | 0.61x | Rs3.64 Billion | Rs2.23 Billion | ▼ -7.2% |
| 2022 | 0.66x | Rs7.91 Billion | Rs5.22 Billion | ▲ +74.6% |
| 2021 | 0.38x | Rs6.05 Billion | Rs2.29 Billion | ▲ +36.2% |
| 2020 | 0.28x | Rs7.01 Billion | Rs1.95 Billion | ▼ -62.1% |
| 2019 | 0.73x | Rs1.85 Billion | Rs1.36 Billion | ▲ +73.9% |
| 2018 | 0.42x | Rs2.02 Billion | Rs851.75 Million | ▲ +72.8% |
| 2017 | 0.24x | Rs4.76 Billion | Rs1.16 Billion | — |